Table 1. Clinicopathological background in 109 patients with endometrioid endometrial cancer.
| Parameter | Criteria | N (%) |
|---|---|---|
| Median follow-up | 64 months | |
| Age | <60 | 68 (62) |
| ⩾60 | 41 (38) | |
| Stage | I | 67 (61) |
| II | 9 (8) | |
| III | 28 (26) | |
| IV | 5 (5) | |
| Histological grade | 1 | 77 (71) |
| 2 | 22 (20) | |
| 3 | 10 (9) | |
| Tumour size | ⩽5 cm | 64 (59) |
| >5 cm | 45 (41) | |
| Myometrial invasion | No invasion | 17 (16) |
| ⩽1/2 | 70 (64) | |
| >1/2 | 22 (20) | |
| Lymph-node metastasis | Positive | 23 (21) |
| Negative | 86 (79) | |
| Vascular invasion | Positive | 22 (20) |
| Negative | 87 (80) | |
| Lymphatic Invasion | Positive | 23 (21) |
| Negative | 86 (79) | |
| Adjuvant chemotherapy | Yes | 35 (32) |
| No | 74 (68) | |
| Regimen | Paclitaxel and carboplatin | 28 (80) |
| Adriamycin and cisplatin (with or without cyclophosphamide) | 7 (20) | |
| Radiotherapy (whole pelvis) | Yes | 17 (16) |
| No | 92 (84) | |
| Recurrence | Yes | 18 (17) |
| No | 91 (83) | |
| Prognosis | No evidence of disease | 94 (86) |
| Alive with disease | 9 (8) | |
| Death of disease | 6 (6) |